Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Side-Firing Laser Treats "Untreatable" Brain Tumors

By HospiMedica International staff writers
Posted on 04 Jun 2009
An innovative magnetic resonance imaging (MRI)-guided laser surgery method holds promise for thousands of brain tumor patients.

The AutoLITT System uses an MRI-guided laser probe to treat previously surgically inaccessible brain tumors such as glioblastoma multiforme. More...
The laser probe is passed through a small burr hole in the skull to deliver laser interstitial thermal therapy (LITT) to heat and coagulate the tumor. The system consists of a thin (3 mm), side-firing, internally-cooled laser probe that is inserted into the tumor, a control mechanism that enables the surgeon to have axial and rotational control over probe positioning; a standard surgical laser with a wavelength of approximately 1064 nm (such as an Nd:YAG or tuned diode laser); interactive software that enables the surgeon to image the probe, tumor, and surrounding brain tissue; and treatment monitoring software that enables the surgeon to visualize laser firing direction, the resultant thermal bloom, and tissue that has reached thermal damage threshold, all overlaid upon real-time images of the tumor and surrounding brain.

The AutoLITT procedure is performed with the patient placed in a standard 1.5 T MRI scanner; MRI signals measure temperature in and around the tumor, enabling the physician to "see" the tumor and the thermal damage as it happens. The probe tip emits laser energy radially (i.e., sideways) to heat tissue in one direction, while cooling to remove heat from all other directions, which enables the physician to guide the heat to the tumor while preserving neighboring healthy tissue. The AutoLITT System is a product of Monteris Medical (Winnipeg, MB, Canada) and is currently in investigational use at both The Cleveland Clinic (OH, USA) and University Hospitals Case Medical Center (Cleveland, OH, USA).

"The AutoLITT procedure delivers new-found hope for patients who have previously been given limited options in the treatment of their tumors," said James Duncan, president and CEO of Monteris Medical. "The system offers a potential option for patients with tumors that are too difficult or too risky to treat, tumors that don't respond to other treatments, and tumors in patients that are otherwise not good candidates for surgery or radiosurgery."

Related Links:

Monteris Medical
The Cleveland Clinic
University Hospitals Case Medical Center



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.